Literature DB >> 31538093

Handwriting Movement Abnormalities in Symptomatic and Premanifest Huntington's Disease.

Michael Caligiuri1, Chase Snell2, Sungmee Park2, Jody Corey-Bloom2.   

Abstract

BACKGROUND: Kinematic measures of handwriting movements are sensitive to mild subclinical motor abnormalities stemming from a wide range of disorders involving the basal ganglia including Huntington's disease (HD). Prior research has not investigated handwriting movements in at-risk individuals in the premanifest stage of HD.
OBJECTIVES: The purpose of this study was to examine whether handwriting movement abnormalities are present prior to clinically manifest chorea in HD.
METHODS: A total of 38 symptomatic HD, 30 gene-positive premanifest, and 25 healthy control participants completed handwriting tasks consisting of circles, loops, sentences, and spirals with a noninking pen on a digitizing tablet. Multiple measures of pen stroke kinematics and pressure were measured along with the cognitive and motor status of each participant. Burden of pathology and CAG × age product scores were obtained from each participant with HD.
RESULTS: Participants with HD exhibited significantly longer and more variable stroke durations, decreased handwriting smoothness, and increased and more variable pen pressures when compared with the healthy controls. We found significant positive associations between stroke duration and both burden of pathology and CAG × age product. Results from a discriminant function analysis revealed a 7-factor model that distinguished premanifest from healthy controls with 85% accuracy. Factors in the model included greater variability in stroke amplitude, velocity and pen pressure, higher levels of pen pressure, longer stroke durations, and lower velocities for combinations of handwritten circles, sentences, and spirals.
CONCLUSIONS: These findings support the clinical utility of dynamic measures of handwriting kinematics as a potential early behavioral biomarker in HD.

Entities:  

Keywords:  Huntington's disease; handwriting; kinematics

Year:  2019        PMID: 31538093      PMCID: PMC6749811          DOI: 10.1002/mdc3.12824

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  14 in total

1.  Micrographia in Huntington's disease.

Authors:  Y Iwasaki; K Ikeda; T Shindoh; Y Suga; I Ishikawa; M Hara; A Shibamoto
Journal:  J Neurol Sci       Date:  1999-01-01       Impact factor: 3.181

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Kinematics of signature writing in healthy aging.

Authors:  Michael P Caligiuri; Chi Kim; Kelly M Landy
Journal:  J Forensic Sci       Date:  2014-02-19       Impact factor: 1.832

4.  Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; Alexander B Niculescu; James B Lohr
Journal:  Psychiatry Res       Date:  2010-04-09       Impact factor: 3.222

5.  Objective assessment of progression in Huntington's disease: a 3-year follow-up study.

Authors:  R Reilmann; F Kirsten; L Quinn; H Henningsen; K Marder; A M Gordon
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

6.  Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures.

Authors:  Ralf Reilmann; Stefan Bohlen; Florian Kirsten; E Bernd Ringelstein; Herwig W Lange
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

7.  A quantitative measure of handwriting dysfluency for assessing tardive dyskinesia.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; James B Lohr
Journal:  J Clin Psychopharmacol       Date:  2015-04       Impact factor: 3.153

8.  Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; Alexander B Niculescu; James Lohr
Journal:  Hum Mov Sci       Date:  2009-08-18       Impact factor: 2.161

9.  Characteristics of handwriting of patients with Huntington's disease.

Authors:  J G Phillips; J L Bradshaw; E Chiu; J A Bradshaw
Journal:  Mov Disord       Date:  1994-09       Impact factor: 10.338

10.  Impaired movement sequencing in patients with Huntington's disease: a kinematic analysis.

Authors:  J G Phillips; E Chiu; J L Bradshaw; R Iansek
Journal:  Neuropsychologia       Date:  1995-03       Impact factor: 3.139

View more
  2 in total

Review 1.  hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible.

Authors:  Pia Rivetti di Val Cervo; Dario Besusso; Paola Conforti; Elena Cattaneo
Journal:  Nat Rev Neurol       Date:  2021-03-03       Impact factor: 42.937

2.  Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.

Authors:  Masatomo Kobayashi; Yasunori Yamada; Kaoru Shinkawa; Miyuki Nemoto; Kiyotaka Nemoto; Tetsuaki Arai
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.